Jeevan Scientific Technology Ltd.

Financial

	Jeevan Scientific	Vivo Bio Tech	Panacea Biotec
Operational Metrics
Financials
5 yr Average ROE	3.53 %	8.97 %	19.34 %
5yr average Equity Multiplier	1.79	2.15	2.01
5yr Average Asset Turnover Ratio	0.61	0.68	0.39
5yr Avg Net Profit Margin	0.57 %	6.47 %	20.95 %
Price to Book	1.64	1.28	1.01
P/E	0.0	17.35	0.0
5yr Avg Cash Conversion Cycle	-174.1 Days	59.58 Days	-83.17 Days
Inventory Days	10.67 Days	68.39 Days	118.8 Days
Days Receivable	97.32 Days	85.27 Days	54.62 Days
Days Payable	625.46 Days	102.47 Days	284.35 Days
5yr Average Interest Coverage Ratio	4.72	2.21	2.91
5yr Avg ROCE	10.37 %	14.59 %	-10.17 %
5yr Avg Operating Profit Margin	19.0 %	29.52 %	-2.87 %
5 yr average Debt to Equity	0.4	0.98	0.41
5yr CAGR Net Profit	n/a	3.33 %	n/a
5yr Average Return on Assets	2.85 %	4.47 %	7.46 %
Shareholdings
Promoter Holding	38.7 %	42.08 %	73.59 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.59 %	5.5 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	-1.27 %

Business

	Jeevan Scientific	Vivo Bio Tech	Panacea Biotec
Product Wise Break-Up	Product Wise Break-Up CRO - Domestic 67.15 CRO 32.85 0 IT Consultancy Service Charges - Export 0 Contract Research Organization(CRO) 0 Research and Development 0 Formulations 0 Vaccines 0	Product Wise Break-Up Formulations 0 0 CRO 0 CRO 100.0 Research and Development 0 CRO - Domestic 0 Vaccines 0 IT Consultancy Service Charges - Export 0	Product Wise Break-Up Formulations 36.72 0 CRO 0 Contract Research Organization(CRO) 0 Research and Development 0 CRO - Domestic 0 Vaccines 63.28 IT Consultancy Service Charges - Export 0
Location Wise Break-Up	Location Wise Break-Up India 67.15 Rest of the World 0 India 0 Others 32.85	-	Location Wise Break-Up India 24.12 Rest of the World 75.88
Operating Profit Break-Up	Operating Profit Break-Up CRO 100.0 Information Technology Services 0	-	Operating Profit Break-Up Information Technology Services 0 CRO 0 Others 100
Capex	Capex CRO 84.74 Software Services 15.26 Real estate 0 Formulations 0 Vaccines 0	-	Capex Formulations 29.97 Real estate 0 Software Services 0 Vaccines 70.03 CRO 0
Asset Break-Up	Asset Break-Up CRO 97.0 Software Services 3.0 Real Estate 0 Formulations 0 Vaccines 0	-	Asset Break-Up Formulations 35.15 Real Estate 0 Software Services 0 Vaccines 64.85 CRO 0
Segment Wise Break-Up	Segment Wise Break-Up CRO 100.0 Information Technology Services 0	-	-